Virax Biolabs Group Limited
VRAX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,229 | $3,589 | $9,353 | $22 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $31 | $218 | $0 | $0 |
| Inventory | $95 | $60 | $24 | $21 |
| Other Curr. Assets | $539 | $513 | $281 | $6 |
| Total Curr. Assets | $4,894 | $4,380 | $9,634 | $49 |
| Property Plant & Equip (Net) | $1,533 | $1,104 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $40 | $50 | $178 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$40 | -$50 | -$178 | $0 |
| Total NC Assets | $1,533 | $1,104 | $178 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,427 | $5,484 | $9,812 | $49 |
| Liabilities | – | – | – | – |
| Payables | $56 | $46 | $160 | $846 |
| Short-Term Debt | $85 | $48 | $146 | $0 |
| Tax Payable | $7 | $12 | $14 | $0 |
| Deferred Revenue | $0 | $0 | $38 | -$0 |
| Other Curr. Liab. | $525 | $63 | $550 | $399 |
| Total Curr. Liab. | $673 | $169 | $908 | $1,245 |
| LT Debt | $292 | $176 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $292 | $176 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $345 | $224 | $0 | $0 |
| Total Liabilities | $965 | $345 | $908 | $1,245 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $3 | $2 | $1 |
| Retained Earnings | -$24,589 | -$18,528 | -$11,794 | -$6,337 |
| AOCI | $30,281 | $23,892 | $20,919 | $5,361 |
| Other Equity | $0 | $0 | -$0 | $0 |
| Total Equity | $5,696 | $5,367 | $9,126 | -$975 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$234 | -$228 | -$222 | -$222 |
| Total Liab. & Tot. Equity | $6,427 | $5,484 | $9,812 | $49 |
| Net Debt | -$3,852 | -$3,365 | -$9,206 | -$22 |